Hepatitis B virus persistence and reactivation

被引:123
|
作者
Shi, Yu [1 ,2 ,3 ]
Zheng, Ming [1 ,2 ,3 ]
机构
[1] Zhejiang Univ, State Key Lab Diag & Treatment Infect Dis, Affiliated Hosp 1, Sch Med, Hangzhou, Peoples R China
[2] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Peoples R China
[3] Natl Clin Res Ctr Infect Dis, Hangzhou, Peoples R China
来源
关键词
T-CELL RESPONSES; CLOSED CIRCULAR DNA; RESOLVED HBV INFECTION; HEPATOCELLULAR-CARCINOMA; LAMIVUDINE THERAPY; ANTIVIRAL THERAPY; CANCER-PATIENTS; E-ANTIGEN; LIVER-TRANSPLANTATION; PREEMPTIVE LAMIVUDINE;
D O I
10.1136/bmj.m2200
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hepatitis B virus (HBV) infection causes chronic hepatitis and has long term complications. Individuals ever infected with HBV are at risk of viral reactivation under certain circumstances. This review summarizes studies on HBV persistence and reactivation with a focus on the definitions and mechanisms. Emphasis is placed on the interplay between HBV replication and host immunity as this interplay determines the patterns of persistence following viral acquisition. Chronic infections exhibit as overt persistence when a defective immune response fails to control the viral replication. The HBV genome persists despite an immune response in the form of covalently closed circular DNA (cccDNA) and integrated DNA, rendering an occult state of viral persistence in individuals whose infection appears to have been resolved. We have described HBV reactivation that occurs because of changes in the virus or the immune system. This review aims to raise the awareness of HBV reactivation and to understand how HBV persists, and discusses the risks of HBV reactivation in a variety of clinical settings.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Drugs and hepatitis B virus reactivation
    Du L.
    Ma Y.
    Tang H.
    Shengwu Yixue Gongchengxue Zazhi/Journal of Biomedical Engineering, 2022, 39 (03): : 627 - 632
  • [2] REACTIVATION OF HEPATITIS-B VIRUS
    不详
    LANCET, 1977, 1 (8011): : 578 - 580
  • [3] the Study of Hepatitis B Virus Reactivation
    Zhao-chun Chi
    Infection International(Electronic Edition), 2014, 3 (04) : 187 - 192
  • [4] Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer
    Torres, Harrys A.
    Davila, Marta
    NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (03) : 156 - 166
  • [5] Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer
    Harrys A. Torres
    Marta Davila
    Nature Reviews Clinical Oncology, 2012, 9 : 156 - 166
  • [6] Mechanisms of Hepatitis B Virus Persistence
    Tsai, Kuen-Nan
    Kuo, Cheng-Fu
    Ou, Jing-Hsiung James
    TRENDS IN MICROBIOLOGY, 2018, 26 (01) : 33 - 42
  • [7] Hepatitis B virus reactivation associated with ruxolitinib
    Chien-Heng Shen
    Cih-En Hwang
    Yi-Yang Chen
    Chih-Cheng Chen
    Annals of Hematology, 2014, 93 : 1075 - 1076
  • [8] Immunosuppressive Therapy and Hepatitis B Virus Reactivation
    Koksal, Iftihar
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2016, 22 (03): : 69 - 73
  • [9] Hepatitis B virus reactivation and alemtuzumab therapy
    Iannitto, E
    Minardi, V
    Calvaruso, G
    Mulè, A
    Ammatuna, E
    Trapani, RD
    Ferraro, D
    Abbadessa, V
    Craxí, A
    Stefano, RD
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 74 (03) : 254 - 258
  • [10] Hepatitis B Virus Reactivation Potentiated by Biologics
    Ogawa, Eiichi
    Wei, Mike T.
    Nguyen, Mindie H.
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2020, 34 (02) : 341 - +